Page last updated: 2024-08-22

vasotocin and Fetal Death

vasotocin has been researched along with Fetal Death in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bratholm, P; Christensen, NJ; Engstrøm, T; Vilhardt, H	1
Creasy, GW; Goodwin, TM; Lane, R; Perry, KG; Romero, R; Sanchez-Ramos, L; Shangold, G; Sibai, BM; Smith, J; Tabor, B; Valenzuela, GJ; Varner, M; Veille, JC	1
Besinger, RE; Gianopoulos, JG; Mittendorf, R; Pryde, PG	1

Reviews

1 review(s) available for vasotocin and Fetal Death

Article	Year
Adverse and beneficial effects of tocolytic therapy. Seminars in perinatology, 2001, Volume: 25, Issue:5 Topics: Adrenergic beta-Agonists; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Fetal Death; Fetal Diseases; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Oxytocin; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents; Vasotocin	2001

Trials

2 trial(s) available for vasotocin and Fetal Death

Article	Year
An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:5 Topics: Double-Blind Method; Female; Fetal Death; Fetal Distress; Gestational Age; Humans; Obstetric Labor, Premature; Placebos; Pregnancy; Time Factors; Tocolysis; Tocolytic Agents; Treatment Outcome; Vasotocin	2000
Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 98, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Female; Fetal Death; Hormone Antagonists; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Outcome; Uterine Contraction; Vasotocin	2001

Article

Year

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.

American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:5

Topics: Double-Blind Method; Female; Fetal Death; Fetal Distress; Gestational Age; Humans; Obstetric Labor, Premature; Placebos; Pregnancy; Time Factors; Tocolysis; Tocolytic Agents; Treatment Outcome; Vasotocin

2000

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.

European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 98, Issue:2

Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Female; Fetal Death; Hormone Antagonists; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Outcome; Uterine Contraction; Vasotocin

2001

Other Studies

1 other study(ies) available for vasotocin and Fetal Death

Article	Year
Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats. Biology of reproduction, 1999, Volume: 60, Issue:2 Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cell Membrane; Female; Fetal Death; Gestational Age; Hormone Antagonists; Myometrium; Oxytocin; Pregnancy; Pregnancy Outcome; Propanolamines; Rats; Receptors, Adrenergic, beta-2; Receptors, Oxytocin; RNA, Messenger; Uterine Contraction; Vasotocin	1999

Article

Year

Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.

Biology of reproduction, 1999, Volume: 60, Issue:2

Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cell Membrane; Female; Fetal Death; Gestational Age; Hormone Antagonists; Myometrium; Oxytocin; Pregnancy; Pregnancy Outcome; Propanolamines; Rats; Receptors, Adrenergic, beta-2; Receptors, Oxytocin; RNA, Messenger; Uterine Contraction; Vasotocin

1999